viewCellular Goods PLC

Cellular Goods signs supply agreement ahead of autumn launch of skincare range

"Cellular Goods are at the forefront of developing premium consumer cannabinoid products in the United Kingdom," said Trevor Peters, Willow's CEO

Cellular Goods PLC -

Cellular Goods PLC (LON:CBX) signed a multi-year supply agreement for cannabigerol (CBG) with Toronto-listed Willow Biosciences.

Willow will supply Cellular Goods with its proprietary, ultra-pure, biosynthetically produced, cannabigerol to be used in Cellular Goods' premium cannabinoid-based skincare products which will be launched in the autumn of 2021.

"Successful products start with the best ingredients and being able to source consistent, highly pure cannabinoids via cellular agriculture from a trusted provider like Willow is essential to our business. CBG is the most promising cannabinoid for skincare applications and we believe it will become a must-have upgrade to people's daily routines,” said Alexis Abraham, the chief executive officer of Cellular Goods.

“Cellular Goods will be the first to bring a range to market in the UK built on our core principles of delivering efficacy-led and research-backed consumer cannabinoid products,” Abraham added.

Shares in Cellular Goods rose 2.8% to 7.25p following the announcement.

Quick facts: Cellular Goods PLC


Price: 5.95 GBX

Market Cap: £30.03 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


Cellular Goods signs multi-year manufacture and supply agreement for...

Cellular Goods PLC (LSE:CBX, FRA:6XS)'s (LON:CBX) Alexis Abraham talks to Proactive London's Katie Pilbeam about signing a multi-year manufacture and supply agreement with Chanelle McCoy Health Ltd (CMH).  As Abraham explains 'we identified an opportunity with a company that very much shared...

on 16/8/21

2 min read